FDA approves Mylan's epilepsy generic

PITTSBURGH The Food and Drug Administration has approved a generic version of an epilepsy drug made by Mylan, the company announced Friday.

The generic drug maker received FDA approval for its levetiracetam tablets in the 1,000-mg strength. The company already markets the drug in the 250-mg, 500-mg and 750-mg strengths.

The drug is a generic version of UCB Pharma’s Keppra. Levetiracetam in the 1,000-mg strength had sales of $136 million during the 12-month period ended Sept. 30, according to IMS Health.